Background The cerebral embolic protection (CEP) device captures embolic debris during
transcatheter aortic valve replacement (TAVR). However, the impact of CEP on stroke severity …

Novel devices for managing heart failure : Current Opinion in Cardiology Novel devices for
managing heart failure : Current Opinion in Cardiology Log in or Register Subscribe to …

Background Computed tomography angiography (CTA) and invasive coronary angiography
(ICA) are routinely performed before transcatheter aortic valve replacement (TAVR) to …

Background Peripheral vascular intervention (PVI) is occasionally required to facilitate
delivery system insertion or to treat vascular complications during transfemoral transcatheter …

Background and Aims In transcatheter aortic valve replacement (TAVR) recipients, the optimal
management of concomitant chronic obstructive coronary artery disease (CAD) remains …

Despite significant advances in pharmacological, electrophysiological and valve therapies
for heart failure with reduced ejection fraction (HFrEF), the associated morbidity, mortality and …

Mitral regurgitation is one of the most prevalent valvulopathies with a disease burden that
incurs significant healthcare costs globally. Surgical repair of the posterior mitral valve leaflet is …

Degenerative calcific aortic stenosis (AS) is the most common valvular heart disease and
often co-exists with left ventricular (LV) systolic dysfunction at the time of diagnosis. Impaired …

Dr. Makar has been a consultant for Abbott; has received research grants from Edwards
Lifesciences, Abbott, Medtronic, and Boston Scientific; is the national principal investigator for …

Left ventricular outflow tract (LVOT) obstruction from the displaced prosthetic anterior mitral
leaflet is a life‐threatening complication that can occur during valve‐in‐valve (ViV) …